iomeprol has been researched along with Atrophy in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozaki, K | 1 |
| Matsui, O | 1 |
| Kobayashi, S | 1 |
| Sanada, J | 1 |
| Koda, W | 1 |
| Minami, T | 1 |
| Kawai, K | 1 |
| Gabata, T | 1 |
1 other study available for iomeprol and Atrophy
| Article | Year |
|---|---|
Selective atrophy of the middle hepatic venous drainage area in hepatitis C-related cirrhotic liver: morphometric study by using multidetector CT.
Topics: Adult; Aged; Aged, 80 and over; Atrophy; Chi-Square Distribution; Contrast Media; Female; Hepatic Ve | 2010 |